Atiq Rehman, MD
Interventional Pain Medicine · Morris, ILNPI 1457373730
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 90.7% of the total across 77 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 14.1% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for interventional pain medicine clinicians in IL, where the typical reported total is $2,254.
Across 77 payments — averaging $25.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nalu Medical, Inc.$275
- Averitas Pharma Inc.$233
- GRT US Holding, Inc.$196
- Intuitive Surgical$180
- AbbVie$155
- Medtronic$155
- plus $753 from 18 others
What the payments were for
- Travel & lodging$1809%
- Food & beverage$1,76691%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nalu Medical, Inc. | 13 | $275 |
| Averitas Pharma Inc. | 8 | $233 |
| GRT US Holding, Inc. | 9 | $196 |
| Intuitive Surgical | 2 | $180 |
| AbbVie(2 entities) | 7 | $155 |
| Medtronic(2 entities) | 8 | $155 |
| Abbott | 6 | $142 |
| Avanos Medical | 1 | $79 |
| AstraZeneca | 1 | $77 |
| Stratus Medical, LLC | 3 | $76 |
| Collegium Pharmaceutical, Inc. | 5 | $75 |
| Boston Scientific | 1 | $51 |
| Atricure, Inc. | 1 | $39 |
| Pacira Therapeutics, Inc. | 2 | $35 |
| Scilex Pharmaceuticals Inc. | 1 | $24 |
| Si-bone, Inc. | 1 | $24 |
| Stimwave Technologies Incorporated | 1 | $22 |
| Baxter Healthcare | 1 | $19 |
| Valinor Pharma, LLC | 1 | $19 |
| Foundation Fusion Solutions, LLC | 1 | $19 |
| Ferring Pharmaceuticals Inc. | 1 | $16 |
| Curonix LLC | 1 | $13 |
| Fidia Pharma USA Inc. | 1 | $12 |
| Vertiflex, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,947 in reported general payments places this provider in the 45th percentile of 93 interventional pain medicine providers in Illinois.
See all interventional pain medicine providers in Illinois →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 411 | $10,091 |
| NucyntaTapentadol Hcl | 13 | $9,704 |
| Hydromorphone ErHydromorphone Hcl | 13 | $3,681 |
| Gabapentin | 237 | $3,006 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 62 | $2,188 |
| Celecoxib | 70 | $2,140 |
| Cyclobenzaprine Hcl | 72 | $1,443 |
| Pregabalin | 56 | $900 |
| Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine | 13 | $805 |
| Tizanidine Hcl | 61 | $701 |
| Oxycodone Hcl | 33 | $554 |
| Tramadol Hcl | 70 | $454 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 35 | $396 |
| Diclofenac Sodium | 24 | $370 |
| Duloxetine Hcl | 33 | $236 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Nucynta | $75 | $9,70413 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 93 interventional pain medicine providers in Illinois.
Other interventional pain medicine in Morris
- Alexander FeoktistovNorthfield$922K
- Timothy LubenowChicago$556K
- Sandeep AminChicago$430K
- Matthew JaycoxChicago$123K
- Hong VoChicago$91K
- Asokumar BuvanendranChicago$52K
- Ramsin BenyaminBloomington$32K
- Adam YoungChicago$29K
- Salman SagarwalaChicago$26K
- Jay JoshiDeer Park$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.